1,5-Xylyl-aethylcarbinol | 104174-12-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1,5-Xylyl-aethylcarbinol
• 英文别名: (+/-)-1-[2.5]xylyl-propanol-(1)；(+/-)-1-Hydroxy-1-(2.5-dimethyl-phenyl)-propan；1-(2,5-Dimethylphenyl)-1-propanol；1-(2,5-dimethylphenyl)propan-1-ol
• CAS: 104174-12-1
• 化学式: C₁₁H₁₆O
• 分子量: 164.247
• InChiKey: VHFHVLYXKPLTID-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 aluminum isopropoxide 、 异丙醇 作用下， 生成 1,5-Xylyl-aethylcarbinol
  参考文献：
  名称：

  Ketones, Carbinols and Hydrocarbons Containing the p-Xylyl Group

  摘要：

  DOI：

  10.1021/ja01174a524

文献信息

• [EN] CRYSTALLINE SOLVATES OF NUCLEOSIDE PHOSPHOROAMIDATES, THEIR STEREOSELECTIVE PREPARATION, NOVEL INTERMEDIATES THEREOF, AND THEIR USE IN THE TREATMENT OF VIRAL DISEASE<br/>[FR] SOLVATES CRISTALLINS DE NUCLÉOSIDE PHOSPHOROAMIDATES, LEUR PRÉPARATION STÉRÉOSÉLECTIVE, NOUVEAUX INTERMÉDIAIRES DE CEUX-CI ET LEUR UTILISATION DANS LE TRAITEMENT D'UNE MALADIE VIRALE
  申请人：INHIBITEX INC

  公开号：WO2013066991A1

  公开（公告）日：2013-05-10

  This invention is directed to novel crystalline solvates of the (S)-P diastereomer of the anti- HCV nucleoside phosphoroamidate, (2S)-neopentyl 2-((((2R,3R,4R,5R)-5-(2-amino-6- methoxy-9H-purin-9-yl)-3,4-dihydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(naphthalen- l-yloxy)phosphorylamino)propanoate (also referred to as INX-08189 or IΝΧ-189), and to a recrystallization method for separating the two diastereomers of INX-08189. In addition, this application relates to a novel stereoselective method for the preparation of either of the two diastereomers, and to the novel synthetic intermediates used in this stereoselective synthesis. The invention also relates to the use of the crystalline solvates to increase the liver exposure of 2'-C-methyl guanosine triphosphate from an oral dose.

  该发明涉及抗HCV核苷磷酸酰胺的(S)-P对映体的新型晶体溶剂化合物，(2S)-新戊基2-((((2R,3R,4R,5R)-5-(2-氨基-6-甲氧基-9H-嘌呤-9-基)-3,4-二羟基-4-甲基四氢呋喃-2-基)甲氧基)(萘基氧基)磷酰胺)丙酸酯（也称为INX-08189或INX-189），以及用于分离INX-08189两个对映体的重结晶方法。此外，该申请涉及一种新颖的立体选择性制备两个对映体的方法，以及用于这种立体选择性合成的新型合成中间体。该发明还涉及利用晶体溶剂化合物提高2'-C-甲基鸟苷三磷酸酯从口服剂量中的肝脏暴露。
• Processes for preparing optically active alcohols and optically active amines
  申请人：SUMITOMO CHEMICAL COMPANY, LIMITED

  公开号：EP0736509A2

  公开（公告）日：1996-10-09

  A process for preparing an optically active alcohol by reacting a prochiral ketone corresponding to the optically active alcohol and an acid with a mixture of (1) a boron-containing compound selected from the group consisting of i) a borane compound which is obtained from an optically active β-aminoalcohol and a boron hydride; or obtained from the optically active β-aminoalcohol, a metal borohydride and an acid and ii) an optically active oxazaborolidine and (2) a metal borohydride; and a process for preparing an optically active amine by reacting an oxime derivative and an acid with a mixture of (1) a boron-containing compound selected from the group consisting of i) a borane compound which is obtained from an optically active β-aminoalcohol and a boron hydride, or obtained from said optically active β-aminoalcohol, a metal borohydride and an acid and ii) an optically active oxazaborolidine, and (2) a metal borohydride.

  一种制备光学活性醇的工艺，其方法是将对应于光学活性醇的手性酮和酸与(1)选自以下组别的含硼化合物和(2)选自以下组别的含硼化合物的混合物反应：①从光学活性β-氨基醇和氢化硼中得到的硼烷化合物；或从光学活性β-氨基醇、金属硼氢化物和酸中得到的硼烷化合物；②光学活性噁唑硼烷和(2)金属硼氢化物；以及一种制备光学活性胺的工艺，其方法是使肟衍生物和酸与(1)一种含硼化合物与(2)一种金属硼氢化物的混合物反应，该含硼化合物选自以下组别：(1)一种硼烷化合物，该硼烷化合物由光学活性β-氨基醇和硼氢化物得到，或由所述光学活性β-氨基醇、金属硼氢化物和酸得到；以及(2)一种光学活性噁唑硼烷和(2)一种金属硼氢化物。